| Literature DB >> 16400147 |
Per Svenningsson1, Karima Chergui, Ilan Rachleff, Marc Flajolet, Xiaoqun Zhang, Malika El Yacoubi, Jean-Marie Vaugeois, George G Nomikos, Paul Greengard.
Abstract
The pathophysiology of depression remains enigmatic, although abnormalities in serotonin signaling have been implicated. We have found that the serotonin 1B receptor [5-hydroxytryptamine (5-HT1B) receptor] interacts with p11. p11 increases localization of 5-HT1B receptors at the cell surface. p11 is increased in rodent brains by antidepressants or electroconvulsive therapy, but decreased in an animal model of depression and in brain tissue from depressed patients. Overexpression of p11 increases 5-HT1B receptor function in cells and recapitulates certain behaviors seen after antidepressant treatment in mice. p11 knockout mice exhibit a depression-like phenotype and have reduced responsiveness to 5-HT1B receptor agonists and reduced behavioral reactions to an antidepressant.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16400147 DOI: 10.1126/science.1117571
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728